Merck & Co., Inc. is 159.4x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($293.16 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIP | MRK |
|---|---|---|
| Market cap | $1.84 B | $293.16 B |
| US-listed rank | #2158 | #44 |
| Revenue (latest FY) | $883.37M | $65.01B |
| Net income (latest FY) | $78.00M | $18.25B |
| Net margin | 8.8% | 28.1% |
| P/E (trailing FY) | 23.6 | 16.1 |
| SEC filings | 1,742 | 996 |
Merck & Co., Inc. is 159.4x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($293.16 B vs $1.84 B).
In their latest fiscal years, ANI PHARMACEUTICALS INC reported $883.37M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ANI PHARMACEUTICALS INC and Merck & Co., Inc., or browse the full rankings.